Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Anti-Aging Properties of Temulawak Extract (Curcuma xanthorrhiza L.) by In Vitro Assay

Folia Medica Indonesiana · Vol. 59 No. 4 (2023) · pp. 350–356

DOI
10.20473/fmi.v59i4.44944
ISSN
2355-8393, 2599-056X
Published
2023-12-10
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

Highlights:1. Elastase, hyaluronidase, and tyrosinase can all be inhibited by temulawak extract.2. Temulawak extract has strong anti-aging ability and can be used as a candidate for cosmetic applications. AbstractThe process of aging is the gradual loss of a tissue's capacity to heal and maintain normal or physiological form and function. Elastase, hyaluronidase, and tyrosinase are the enzymes that contribute to skin aging. The anti-aging effect is connected to the inhibition of these enzymes' activity. Many medicinal plants with active metabolite have been utilized extensively to treat aging. Active compounds of temulawak (Curcuma xanthorrhiza L.) such as phenolic, curcuminoid and xanthorrhizol have potential as antiaging. This study aims to determine whether temulawak extract (TE), a potential candidate for cosmeceutical agent, has anti-aging characteristics by inhibiting the elastase, hyaluronidase, and tyrosinase enzymes. TE was processedxby PT FAST. Stock solution of TE was made by dissolving 20 mg of extract with 1 ml of DMSO 100%, the stock solution was then diluted to achieve the concentrations level 31.25 - 1000 μg/ml working solution of TE. The antiaging activity assays were carried out at PT Aretha Medika Utama. In vitro antiaging assay of TE includes elastase, hyaluronidase, and tyrosinase enzyme inhibition at 7 level of various concentrations of 2.08-66.67 μg/ml for anti-elastase assay, 5.21-166.67 μg/ml for anti-hyaluronidase assay, and 3.125-100 μg/ml for anti-tyrosinase assay with three replications. SPSS software was used to conduct the statistical analysis (p<0,05 is considered significant). TE exhibited highest inhibition percentage of 82.72%, 89.41%, and 94.17% for anti-tyrosinase, anti-elastase, and anti-hyaluronidase, respectively. The median inhibitory concentration (IC50) for elastase inhibitory activity was 10.66 μg/ml, hyaluronidase 70.39 μg/ml, and tyrosinase 55.87 μg/ml. According to this study, TE can be used as cosmeceu

Keywords

Collaboration network of the authors

40 authors · 202 co-authorship links · 82 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Maranatha Christian University
  • Universitas Prima Indonesia
  • Bandung Institute of Technology
  • University of Indonesia
  • Indonesian Institute of Sciences
  • Padjadjaran University
  • Universiti Sains Malaysia
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Hanna Sari Widya KusumaAffiliation unknown11
Rizal RizalUniversity of Indonesia10
Ervi AfifahAffiliation unknown7
Ermi GirsangUniversitas Prima Indonesia7
Dhanar Septyawan HadiprasetyoUniversitas Jenderal Achmad Yani6
Tjandrawati MozefIndonesian Institute of Sciences5
Seila ArumwardanaAffiliation unknown4
Didik PriyandokoIndonesia University of Education4
Rizal AzisUniversity of Indonesia4
Chrismis Novalinda GintingUniversitas Prima Indonesia4
I Nyoman Ehrich ListerUniversitas Prima Indonesia4
Hana RatnawatiMaranatha Christian University3
Ferry SandraUniversitas Trisakti3
Dwi Davidson RihibihaAffiliation unknown3
Annisa AmaliaBandung Institute of Technology3
Diana Krisanti JasaputraMaranatha Christian University3
The Fransiska EltaniaMaranatha Christian University3
Ahmad FariedPadjadjaran University3
Fadhilah Haifa ZahirohAffiliation unknown3
Chandra RisdianIndonesian Institute of Sciences3
Lusiana DarsonoMaranatha Christian University2
Ika Adhani SholihahBandung Institute of Technology2
Djaja RusmanaMaranatha Christian University2
Philips OnggowidjajaMaranatha Christian University2
Agung NoviantoPadjadjaran University2
Ali Napiah NasutionUniversitas Prima Indonesia2
Harry MurtiAffiliation unknown2
Indra BachtiarAffiliation unknown2
Wahyu Setia WidodoAffiliation unknown2
Susi EndriniYarsi University2
Maesaroh MaesarohUniversitas Muhammadiyah Prof Dr Hamka2
Jo SuhermanMaranatha Christian University1
Yukko ArintaAffiliation unknown1
Tri Aprilia SuciatiBandung Institute of Technology1
NH IsmailUniversiti Sains Malaysia1
RAR AwangUniversiti Sains Malaysia1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Anti-Aging Properties of Temulawak Extract (Curcuma xanthorrhiza L.) by In Vitro Assay</dc:title><dc:creator>Teresa Liliana Wargasetia</dc:creator><dc:creator>Wahyu Widowati</dc:creator><dc:creator>Anis Syabani Muthmainnah</dc:creator><dc:creator>Rizal</dc:creator><dc:subject>Curcuma xanthorrhiza</dc:subject><dc:subject>anti-aging effects</dc:subject><dc:subject>skin aging</dc:subject><dc:subject>elastase inhibition</dc:subject><dc:subject>hyaluronidase inhibition</dc:subject><dc:subject>tyrosinase inhibition</dc:subject><dc:subject>xanthorrhizol</dc:subject><dc:subject>curcuminoids</dc:subject><dc:subject>phenolic compounds</dc:subject><dc:subject>cosmeceuticals</dc:subject><dc:subject>plant extracts</dc:subject><dc:subject>IC50</dc:subject><dc:subject>enzyme inhibition</dc:subject><dc:subject>cosmetic ingredients</dc:subject><dc:subject>medicinal plants</dc:subject><dc:description xml:lang="en">Highlights:1. Elastase, hyaluronidase, and tyrosinase can all be inhibited by temulawak extract.2. Temulawak extract has strong anti-aging ability and can be used as a candidate for cosmetic applications. AbstractThe process of aging is the gradual loss of a tissue's capacity to heal and maintain normal or physiological form and function. Elastase, hyaluronidase, and tyrosinase are the enzymes that contribute to skin aging. The anti-aging effect is connected to the inhibition of these enzymes' activity. Many medicinal plants with active metabolite have been utilized extensively to treat aging. Active compounds of temulawak (Curcuma xanthorrhiza L.) such as phenolic, curcuminoid and xanthorrhizol have potential as antiaging. This study aims to determine whether temulawak extract (TE), a potential candidate for cosmeceutical agent, has anti-aging characteristics by inhibiting the elastase, hyaluronidase, and tyrosinase enzymes. TE was processedxby PT FAST. Stock solution of TE was made by dissolving 20 mg of extract with 1 ml of DMSO 100%, the stock solution was then diluted to achieve the concentrations level 31.25 - 1000 μg/ml working solution of TE. The antiaging activity assays were carried out at PT Aretha Medika Utama. In vitro antiaging assay of TE includes elastase, hyaluronidase, and tyrosinase enzyme inhibition at 7 level of various concentrations of 2.08-66.67 μg/ml for anti-elastase assay, 5.21-166.67 μg/ml for anti-hyaluronidase assay, and 3.125-100 μg/ml for anti-tyrosinase assay with three replications. SPSS software was used to conduct the statistical analysis (p&lt;0,05 is considered significant). TE exhibited highest inhibition percentage of 82.72%, 89.41%, and 94.17% for anti-tyrosinase, anti-elastase, and anti-hyaluronidase, respectively. The median inhibitory concentration (IC50) for elastase inhibitory activity was 10.66 μg/ml, hyaluronidase 70.39 μg/ml, and tyrosinase 55.87 μg/ml. According to this study, TE can be used as cosmeceu</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2023-12-10</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v59i4.44944</dc:identifier><dc:identifier>10.20473/fmi.v59i4.44944</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 59 No 4 (2023); 350-356</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/44944/27340</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>